← Leaderboards
Sang Ging Ong
Stanford University
$4,302,589
Attributed
$4,302,589
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $841.1K · FY2016–25$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,302,589 · 4
By mechanism
R01$3,117,081 · 2
R00$927,121 · 1
K99$258,387 · 1
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- Kevin P White$42,916,246
- Alice Chen Fan$2,474,246
- Margaret T Fuller$21,555,594
- Vanessa Lopezpajares$802,603
- William F Fearon$5,309,897
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsResponseCardiac MyocytesInduced Pluripotent Stem CellDiabetes MellitusPredispositionCardiacDiabetic PatientDiabetic CardiomyopathyPathogenesisPreventPathway InteractionsStressMitochondriaCause Of DeathMolecularHyperglycemiaImpairmentCardiovascular DiseasesHeartDiabeticGeneticBaseAutophagocytosis
Grant awards (13)
Molecular mechanisms of translational control in sunitinib-induced vascular dysfunction$701,890
R01 · FY2025 · HL · contact PI
Rab GTPases-mediated mitochondrial clearance in diabetic cardiomyopathy$411,962
R01 · FY2024 · HL · contact PI
Rab GTPases-mediated mitochondrial clearance in diabetic cardiomyopathy$411,962
R01 · FY2023 · HL · contact PI
Rab GTPases-mediated mitochondrial clearance in diabetic cardiomyopathy$411,962
R01 · FY2022 · HL · contact PI
Dysfunctional Endosomal-Mediated Mitochondrial Clearance Linking Vascular Dysfunction to Alzheimer's Disease: Administrative Supplement for HL148756$355,381
R01 · FY2022 · HL · contact PI
Rab GTPases-mediated mitochondrial clearance in diabetic cardiomyopathy$411,962
R01 · FY2021 · HL · contact PI
Rab GTPases-mediated mitochondrial clearance in diabetic cardiomyopathy$411,962
R01 · FY2020 · HL · contact PI
Cardiac Mitohormesis Protects Against Diabetic Cardiomyopathy Through Mitophagy$248,999
R00 · FY2020 · HL · contact PI
CARDIAC MITOHORMESIS PROTECTS AGAINST DIABETIC CARDIOMYOPATHY THROUGH MITOPHAGY: EVALI ADMINISTRATIVE SUPPLEMENT$180,124
R00 · FY2020 · HL · contact PI
Cardiac Mitohormesis Protects Against Diabetic Cardiomyopathy Through Mitophagy$248,999
R00 · FY2019 · HL · contact PI
Cardiac Mitohormesis Protects Against Diabetic Cardiomyopathy Through Mitophagy$248,999
R00 · FY2018 · HL · contact PI
Cardiac Mitohormesis Protects Against Diabetic Cardiomyopathy Through Mitophagy$130,704
K99 · FY2017 · HL · contact PI
Cardiac Mitohormesis Protects Against Diabetic Cardiomyopathy Through Mitophagy$127,683
K99 · FY2016 · HL · contact PI